Keryx Biopharma Reports Zerenex Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2014 Spring Clinical Meeting
April 09, 2014 at 08:33 AM EDT
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced that Phase 2 clinical results of Zerenex™ (ferric ...
